Publication: The relationship of neutrophil to lymphocyte ratio with testicular cancer
Program
Authors
İlktaç, Abdullah
Akbulut, Habib
Akçay, Muzaffer
Ersöz, Cevper
Doğan, Bayram
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Purpose: To assess the relationship between testicular germ cell tumors (TGCT) and
neutrophil to lymphocyte ratio (NLR) and to determine whether this ratio can be used
as a serum tumor marker.
Material and Methods: Sixty-one patients with testicular germ cell tumors were included into the study. Patients were grouped as localized and non-localized. Histologically patients were categorized as seminoma and nonseminomatous germ cell tumors.
Complete blood cell count was measured the day before surgery and at the postoperative 1st month. Preoperative and postoperative mean NLR values were compared.
Results: Thirty-six patients (59%) had seminomas and 25 patients (41%) had nonseminomatous testicular cancer. Forty-fi ve patients (73.8%) had localized and 16 patients
(26.2%) had non-localized testicular cancer. There was a statistically signifi cant difference between preoperative and postoperative mean NLR of the localized patients
(p=0.001) but no such difference was detected for non-localized patients (p=0.576).
Nineteen patients with localized seminomas had normal preoperative serum tumor
markers. There was a signifi cant difference between preoperative and postoperative
mean NLR in this group of patients (p=0.010). Twenty-six patients with localized tumors had preoperative increased serum tumor markers which normalized after orchiectomy. Mean NLR of these patients signifi cantly decreased from 3.10±2.13 to 1.62±0.59
postoperatively (p=0.010).
Conclusions: NLR appears to be a useful marker for TGCT. It is successful in predicting
localized and non-localized disease in early postoperative period.
Description
Source:
Keywords:
Keywords
Citation
İlktaç A., Doğan B., Ersöz C., Akçay M., Akbulut H., -The relationship of neutrophil to lymphocyte ratio with testicular cancer-, International Braz J Urol, cilt.46, ss.101-107, 2020